Posted by Michael Wonder on 13 Oct 2023
Vueway (gadopiclenol) receives positive CHMP opinion
12 October 2023 - The CHMP of the EMA recommended approval of the macrocyclic, high relaxivity Vueway (gadopiclenol) in adults and paediatric patients older than 2 years of age.
Bracco Imaging today received notification that the CHMP of the EMA has adopted a positive opinion recommending approval of Vueway (gadopiclenol) solution for injection for magnetic resonance imaging for use in adult and paediatric patients aged 2 years and older with magnetic resonance imaging of the CNS (brain, spine, and surrounding tissues) and several body organs (liver, kidney, pancreas, breast, lung, prostate, and musculoskeletal system).
